Australian Centre for Artificial Intelligence in Medical Innovation (ACAMI)
The world’s first university innovation centre specialising in the application of artificial intelligence to accelerate the discovery and development of immunotherapies, vaccines and medical innovation
OUR KEY AREAS
The intersection of AI and medical innovation
BioNTech calls La Trobe home
La Trobe University is home to global biotechnology company BioNTech’s state-of-the-art mRNA clinical-scale manufacturing facility at the Melbourne campus in Bundoora, in an agreement facilitated by the Victorian Government. The facility will support researchers to develop investigational mRNA-based treatment options, as well as manufacture investigational candidates for clinical trials in the Asia-Pacific region.
La Trobe is already a world leader in AI and digital innovation. The Australian Centre for AI in Medical Innovation will greatly accelerate the process of translating medical breakthroughs into cost-effective and widely-accessible, personalised cancer vaccines and treatments.
The planned BioNTech facility will establish La Trobe as a centre of a new mRNA technology, providing access not only to its own researchers but also access to collaborators from across Australia and the world.
IN PARTNERSHIP
ACAMI was established through the support of the Victorian Government through mRNA Victoria.
Connect with us
News
-
New research centre focusses on disability
New disability research centre launched with Summer Foundation
-
Jawun Secondment: A Transformative Opportunity
Tshepo Rasekaba, Senior Research Fellow for Rural Aging at La Trobe, has recently returned from a transformative six week-secondment.
-
From Local Roots to Regional Impact: A Research Journey with the La Trobe Industry Research Scholarship
PhD scholar Kahlia Borserio’s career is driven by a deep commitment to improving rural and regional health outcomes.
Events
No upcoming events at the moment. Check back soon.